Pioneering discovery and therapeutics at the brain-vascular-immune interface
Abstract
No abstract availableKeywords
Funding Information
- BrightFocus Foundation
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Institute on Alcohol Abuse and Alcoholism
- Deutsche Forschungsgemeinschaft
This publication has 15 references indexed in Scilit:
- Fibrin drives thromboinflammation and neuropathology in COVID-19Nature, 2024
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionThe Lancet, 2024
- Defining blood-induced microglia functions in neurodegeneration through multiomic profilingNature Immunology, 2023
- Transforming the understanding of brain immunityScience, 2023
- The industrial genomic revolution: A new era in neuroimmunologyNeuron, 2022
- The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosisBrain, 2021
- Causal Associations Between Modifiable Risk Factors and the Alzheimer's PhenomeAnnals of Neurology, 2020
- Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationNature Immunology, 2018
- Fibrinogen in neurological diseases: mechanisms, imaging and therapeuticsNature Reviews Neuroscience, 2018
- The genetics of multiple sclerosis: SNPs to pathways to pathogenesisNature Reviews Genetics, 2008